BFEC
CELG

Benjamin F. Edwards & Company’s Celgene Corp CELG Stock Holding History

Benjamin F. Edwards & Company’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-7,237
Closed -$719K – 1997
2019
Q3 		$719K Buy
7,237
+2,600
+56% +$247K 0.06% 310
2019
Q2 		$429K Buy
4,637
+842
+22% +$80K 0.04% 389
2019
Q1 		$358K Sell
3,795
-4,463
-54% -$390K 0.03% 392
2018
Q4 		$529K Buy
8,258
+1,877
+29% +$139K 0.05% 300
2018
Q3 		$571K Sell
6,381
-7,258
-53% -$641K 0.05% 302
2018
Q2 		$1.08M Sell
13,639
-14
-0.1% -$1.16K 0.11% 202
2018
Q1 		$1.22M Buy
13,653
+7,404
+118% +$711K 0.12% 173
2017
Q4 		$652K Buy
6,249
+569
+10% +$64.2K 0.07% 275
2017
Q3 		$828K Buy
5,680
+1,157
+26% +$158K 0.1% 204
2017
Q2 		$587K Sell
4,523
-105
-2% -$12.9K 0.08% 247
2017
Q1 		$576K Buy
4,628
+357
+8% +$42.7K 0.08% 243
2016
Q4 		$494K Buy
4,271
+1,484
+53% +$165K 0.08% 251
2016
Q3 		$291K Sell
2,787
-150
-5% -$16.2K 0.05% 292
2016
Q2 		$290K Sell
2,937
-164
-5% -$17K 0.06% 276
2016
Q1 		$310K Buy
3,101
+229
+8% +$23.6K 0.06% 252
2015
Q4 		$344K Sell
2,872
-562
-16% -$65K 0.07% 237
2015
Q3 		$371K Buy
3,434
+250
+8% +$31K 0.08% 223
2015
Q2 		$369K Buy
3,184
+646
+25% +$73.9K 0.07% 248
2015
Q1 		$293K Buy
2,538
+1,618
+176% +$193K 0.06% 275
2014
Q4 		$103K Buy
920
+566
+160% +$59.7K 0.02% 387
2014
Q3 		$34K Buy
354
+177
+100% +$16K 0.01% 562
2014
Q2 		$30K Sell
177
-97
-35% -$7.38K 0.01% 549
2014
Q1 		$19K Sell
274
-400
-59% -$31.7K 0.01% 592
2013
Q4 		$57K Hold
674
– – 0.02% 422
2013
Q3 		$52K Hold
674
– – 0.02% 400
2013
Q2 		$39K Buy
+674
New +$40.6K 0.02% 394

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Benjamin F. Edwards & Company's CELG Position: Q4 2019 in Review

Benjamin F. Edwards & Company sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 7,237 shares — an estimated $719K sold.

Benjamin F. Edwards & Company first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $1.22M in Q1 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Benjamin F. Edwards & Company reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 7,237 Celgene Corp shares in Q4 2019, an estimated $719K.
  • Benjamin F. Edwards & Company first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Benjamin F. Edwards & Company's Celgene Corp position peaked at $1.22M in Q1 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Benjamin F. Edwards & Company's 13F filing for Q4 2019, filed 6 Feb 2020.